Prognosis Analysis of Breast Cancer Based on DO-UniBIC Gene Screening Method

2021 ◽  
pp. 215-222
Author(s):  
Xinhong Zhang ◽  
Tingting Hou ◽  
Fan Zhang
Keyword(s):  
Breast Cancer ◽  
Screening Method ◽  
Gene Screening

scholarly journals Cyanuric Chloride Containing Chalcones for Possible Breast Cancer Treatment: Synthesis, Antimicrobial and in silico Screening

2019 ◽  
Vol 32 (2) ◽  
pp. 408-414
Author(s):  
Revathy Selvaraj ◽  
J. Suresh ◽  
A. Arun
Keyword(s):  
Breast Cancer ◽  
In Silico ◽  
Topoisomerase Ii ◽  
Excellent Result ◽  
Screening Method ◽  
Cyanuric Chloride ◽  
Gram Negative Bacteria ◽  
In Silico Screening ◽  
Gram Negative ◽  
Mic Value

In this work, we have synthesized efficient antibacterial compounds with anticancer novel molecules based on cyanuric chloride containing chalcone moiety. For this, novel triazine-based organic molecules were synthesized by using cyanuric chloride and 2,4-dichloro-1-ene(4-hydroxyphenyl)phenone and characterized by elemental analysis, FT-IR, NMR and UV-visible spectrometry techniques. Melting point of the molecules were increased with an increase in substitution on cyanuric chloride. The minimum inhibitory concentration (MIC) value of the synthesized compounds showed an excellent result on Gram-negative bacteria with low MIC value of 1.95 μg/mL. Gram-positive bacteria showed little resistance to the synthesized drug. The synthesized compounds were tested for their use as an anticancer drug using in silico screening method. The synthesized compounds in silico molecular docking method using breast cancer protein (BRCA2) confirms that triazine derivative with all three chlorine molecules replaced by 2,4-dichloro-1-ene(4-hydroxyphenyl)phenone showed highest binding energy with the value of -9.1900 Kcal/mol which is in agreement with the observed high MIC value obtained for Gram-negative bacteria. The synthesized molecules preferentially targeted the topoisomerase II of the bacteria. Overall, an efficient antimicrobial drug is synthesized using a simple preparation method.

scholarly journals Risk factors for the development of brain metastases in patients with HER2-positive breast cancer

ESMO Open ◽  
2018 ◽  
Vol 3 (6) ◽  
pp. e000440 ◽  
Author(s):  
Christian Maurer ◽  
Lorraine Tulpin ◽  
Michel Moreau ◽  
Cristina Dumitrescu ◽  
Evandro de Azambuja ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Brain Metastases ◽  
Cox Regression ◽  
Lung Metastases ◽  
Screening Method ◽  
Outcome Analysis ◽  
Asymptomatic Patients ◽  
Number Of Patients ◽  
Positive Breast Cancer

BackgroundPatients with metastatic human epidermal growth factor receptor 2-positive breast cancer (HER2+ BC) frequently experience brain metastases (BM). We aimed to define risk factors for the development of BM in patients with HER2+ BC and to report on their outcome.MethodsThis is a retrospective analysis of patients diagnosed with HER2+ BC between January 2000 and December 2014 at Institut Jules Bordet, Belgium. Statistical analyses were conducted with SAS V.9.4 using Kaplan-Meier method and Cox regression analyses.ResultsA total of 483 patients were included of whom 108 (22.4%) developed metastases and 52 (10.8%) BM. Among 96 metastatic patients without BM at diagnosis, 40 (41.7%) developed BM in the course of their disease. In multivariate analysis, risk factors for the development of BM were age ≤40 years (HR 2.10, 95 % CI 1.02 to 4.36), tumour size >2 cm (HR 4.94, 95% CI 1.69 to 14.47), nodal involvement (HR 3.48, 95% CI 1.47 to 8.25), absence or late start (≥6 months after initial diagnosis) of adjuvant anti-HER2 treatment (HR 3.79, 95% CI 1.52 to 9.43 or HR 2.65, 95% CI 1.03 to 6.82) and the development of lung metastases as first site of relapse (HR 6.97, 95% CI 3.41 to 14.24). Twenty-two patients with HER2+ BC and BM sent to our institute for further treatment were included in the outcome analysis. Asymptomatic patients at the time of BM diagnosis showed a better overall survival than symptomatic patients (HR 0.49, 95% CI 0.25 to 0.94).ConclusionA considerable number of patients with metastatic HER2+ BC will develop BM. Screening of patients with risk factors for BM might lead to early detection and better outcome. However, randomised controlled trials examining the use of MRI as a screening method for BM in patients with metastatic BC are warranted before such an approach can be recommended.

The Effectiveness of Mammography as a Screening Method to Detect Breast Cancer in High Breast Density Populations

2019 ◽  
Vol 50 (2) ◽  
pp. S3
Author(s):  
Hailey M. Richards ◽  
Chelsea Wandziak ◽  
Ubi Wichoski
Keyword(s):  
Breast Cancer ◽  
Breast Density ◽  
Screening Method ◽  
Detect Breast Cancer

Breast Cancer Gene Screening Guidelines Miss Many Women at Risk

2018 ◽  
Vol 40 (12) ◽  
pp. 31
Author(s):  
Kurt Samson
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Gene ◽  
Screening Guidelines ◽  
Gene Screening ◽  
Breast Cancer Gene

Multimodal Ultrasonic Imaging for Breast Cancer Detection

2012 ◽  
Vol 37 (3) ◽  
pp. 253-260 ◽  
Author(s):  
Jorge Camacho ◽  
Luis Medina ◽  
Jorge F. Cruza ◽  
José M. Moreno ◽  
Carlos Fritsch
Keyword(s):  
Breast Cancer ◽  
Cancer Detection ◽  
Current Practice ◽  
Ultrasonic Transducer ◽  
Screening Method ◽  
Phase Coherence ◽  
Breast Cancer Detection ◽  
Surrounding Tissue ◽  
Dense Breast Tissue ◽  
Breast Phantom

Abstract Ultrasound is used for breast cancer detection as a technique complementary to mammography, the standard screening method. Current practice is based on reflectivity images obtained with conventional instruments by an operator who positions the ultrasonic transducer by hand over the patient’s body. It is a non-ionizing radiation, pain-free and not expensive technique that provides a higher contrast than mammography to discriminate among fluid-filled cysts and solid masses, especially for dense breast tissue. However, results are quite dependent on the operator’s skills, images are difficult to reproduce, and state-of-the-art instruments have a limited resolution and contrast to show micro-calcifications and to discriminate between lesions and the surrounding tissue. In spite of their advantages, these factors have precluded the use of ultrasound for screening. This work approaches the ultrasound-based early detection of breast cancer with a different concept. A ring array with many elements to cover 360◦ around a hanging breast allows obtaining repeatable and operator-independent coronal slice images. Such an arrangement is well suited for multi-modal imaging that includes reflectivity, compounded, tomography, and phase coherence images for increased specificity in breast cancer detection. Preliminary work carried out with a mechanical emulation of the ring array and a standard breast phantom shows a high resolution and contrast, with an artifact-free capability provided by phase coherence processing.

Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis

2019 ◽  
Vol 21 (2) ◽  
pp. 663-675 ◽  
Author(s):  
Hyung-Yong Kim ◽  
Hee-Joo Choi ◽  
Jeong-Yeon Lee ◽  
Gu Kong
Keyword(s):  
Breast Cancer ◽  
Web Application ◽  
Target Gene ◽  
Biological Significance ◽  
Cancer Type ◽  
Omics Data ◽  
Breast Cancer Patients ◽  
Driver Genes ◽  
Cancer Driver ◽  
Gene Screening

Abstract Breast cancer comprises several molecular subtypes with distinct clinical features and treatment responses, and a substantial portion of each subtype remains incurable. A comprehensive analysis of multi-omics data and clinical profiles is required in order to better understand the biological complexity of this cancer type and to identify new prognostic and therapeutic markers. Thus, there arises a need for useful analytical tools to assist in the investigation and clinical management of the disease. We developed Cancer Target Gene Screening (CTGS), a web application that provides rapid and user-friendly analysis of multi-omics data sets from a large number of primary breast tumors. It allows the investigation of genomic and epigenomic aberrations, evaluation of transcriptomic profiles and performance of survival analyses and of bivariate correlations between layers of omics data. Notably, the genome-wide screening function of CTGS prioritizes candidate genes of clinical and biological significance among genes with copy number alteration, DNA methylation and dysregulated expression by the integrative analysis of different types of omics data in customized subgroups of breast cancer patients. These features may help in the identification of druggable cancer driver genes in a specific subtype or the clinical condition of human breast cancer. CTGS is available at http://ctgs.biohackers.net.

A study of atherosclerosis in patients after radiation for early breast cancer.

2011 ◽  
Vol 29 (27_suppl) ◽  
pp. 260-260
Author(s):  
V. G. Kirtani ◽  
M. Chang ◽  
A. M. Dobrescu ◽  
S. Zeldis ◽  
J. A. Haas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Coronary Arteries ◽  
Background Radiation ◽  
Small Sample Size ◽  
Screening Method ◽  
Calcium Score ◽  
Small Sample ◽  
Left Hemithorax ◽  
Asymptomatic Patients ◽  
Number Of Patients

260 Background: Radiation therapy (RT) is widely used as part of curative treatment of breast cancer. However, older studies have shown increased cardiac morbidity and mortality from breast RT. A screening method is needed to detect early cardiac damage in this population. Recent data have shown that Electron beam computed tomography (EBCT) can detect early atherosclerosis in coronary arteries by identifying the amount of calcification in the coronaries. In our study we employed this tool to detect occult atherosclerosis caused by breast RT. Methods: We evaluated 20 asymptomatic patients, less than 60 years of age, treated with RT at least 5 years prior to enrollment. Nine received RT to the left and 11 to the right hemithorax. Average interval between RT and CT was 7.7 years (5-14). All patients were treated with external beam RT using tangential technique. The breast was treated to a dose of 4500-5040 cGy and the tumor bed was boosted to a total dose of 6000-6600 cGy. All patients underwent EBCT to compute the volumetric and agatston calcium scores in the coronary arteries and the aorta. Results: Of the 11 patients who had RT to right hemithorax, 8 had calcium score of 0, 2 had very minimally elevated scores and 1 had significantly elevated score (patient 19, interval -14 years). Of the 9 patients who had RT to left hemithorax, 7 had calcium score of 0. None had significantly elevated scores. In the aorta, 11 patients had score of 0 and 8 had minimally elevated scores. Conclusions: Occult atherosclerosis was not detected using EBCT calcium scores in coronaries and aorta in a significant number of patients treated with RT for breast cancer. However, the study is limited by a small sample size. [Table: see text]

scholarly journals Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay

PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e44640 ◽  
Author(s):  
Wan Yong Ho ◽  
Swee Keong Yeap ◽  
Chai Ling Ho ◽  
Raha Abdul Rahim ◽  
Noorjahan Banu Alitheen
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
High Throughput ◽  
Mtt Assay ◽  
High Throughput Screening ◽  
Screening Method ◽  
Tumor Spheroid ◽  
Multicellular Tumor Spheroid
Sign in / Sign up

Export Citation Format

Share Document